Mechanisms of carotid body chemoreflex dysfunction during heart failure

Experimental Physiology

Volumn 100, Issue 2, 2015, Pages 124-129

  Schultz, Harold D ^a   Marcus, Noah J ^a   Del Rio, Rodrigo ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSIDAD AUTÓNOMA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE; HUMORAL ANTIBODY; KRUPPEL LIKE FACTOR 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

ARTICLE; BREATHING PATTERN; CAROTID ARTERY FLOW; CAROTID BODY CHEMORECEPTOR; CHEMORECEPTOR REFLEX; CHEMOREFLEX DYSFUNCTION; CHEYNE STOKES BREATHING; CHRONIC DISEASE; CHRONIC INTERMITTENT HYPOXIA; ENDOTHELIUM CELL; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART OUTPUT; HUMAN; HYPERACTIVITY; INTERMITTENT HYPOXIA; MEMBRANE STEADY POTENTIAL; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; SENSORY DYSFUNCTION; SHEAR STRESS; SYMPATHETIC TONE; SYSTOLIC HEART FAILURE; ANIMAL; BREATHING; CAROTID BODY; PATHOLOGY; PHYSIOLOGY; REFLEX;

ANIMALS; CAROTID BODY; HEART FAILURE; HUMANS; REFLEX; RESPIRATION;

EID: 84921782296     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2014.079517     Document Type: Article

References (33)

1. Brack T, Randerath W & Bloch KE (2012). Cheyne-Stokes respiration in patients with heart failure: prevalence, causes, consequences and treatments. Respiration 83, 165-176.
2. Chua TP, Ponikowski P, Webb-Peploe K, Harrington D, Anker SD, Piepoli M & Coats AJ (1997). Clinical characteristics of chronic heart failure patients with an augmented peripheral chemoreflex. Eur Heart J 18, 480-486.
3. Dekker RJ, van Thienen JV, Rohlena J, de Jager SC, Elderkamp YW, Seppen J, de Vries CJ, Biessen EA, van Berkel TJ, Pannekoek H & Horrevoets AJ (2005). Endothelial KLF2 links local arterial shear stress levels to the expression of vascular tone-regulating genes. Am J Pathol 167, 609-618.
4. Del Rio R, Marcus NJ & Schultz HD (2013a). Carotid chemoreceptor ablation improves survival in heart failure: rescuing autonomic control of cardiorespiratory function. J Am Coll Cardiol 62, 2422-2430.
5. Del Rio R, Marcus NJ & Schultz HD (2013b). Inhibition of hydrogen sulfide restores normal breathing stability and improves autonomic control during experimental heart failure. J Appl Physiol 114, 1141-1150.
6. Deo SH, Fisher JP, Vianna LC, Kim A, Chockalingam A, Zimmerman MC, Zucker IH & Fadel PJ (2012). Statin therapy lowers muscle sympathetic nerve activity and oxidative stress in patients with heart failure. Am J Physiol Heart Circ Physiol 303, H377-H385.
7. Ding Y, Li YL & Schultz HD (2008). Downregulation of carbon monoxide as well as nitric oxide contributes to peripheral chemoreflex hypersensitivity in heart failure rabbits. J Appl Physiol 105, 14-23.
8. Ding Y, Li YL & Schultz HD (2011). Role of blood flow in carotid body chemoreflex function in heart failure. J Physiol 589, 245-258.
9. Ding Y, Li YL, Zimmerman MC, Davisson RL & Schultz HD (2009). Role of CuZn superoxide dismutase on carotid body function in heart failure rabbits. Cardiovasc Res 81, 678-685.
10. Ding Y, Li YL, Zimmerman MC & Schultz HD (2010). Elevated mitochondrial superoxide contributes to enhanced chemoreflex in heart failure rabbits. Am J Physiol Regul Integr Comp Physiol 298, R303-R311.
11. Downing J & Balady GJ (2011). The role of exercise training in heart failure. J Am Coll Cardiol 58, 561-569.
12. Esler M (2010). The 2009 Carl Ludwig Lecture: Pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management. J Appl Physiol 108, 227-237.
13. Fung ML, Tipoe GL & Leung PS (2014). Mechanisms of maladaptive responses of peripheral chemoreceptors to intermittent hypoxia in sleep-disordered breathing. Sheng Li Xue Bao 66, 23-29.
14. Haack KK, Marcus NJ, Del Rio R, Zucker IH & Schultz HD (2014). Simvastatin treatment attenuates increased respiratory variability and apnea/hypopnea index in rats with chronic heart failure. Hypertension 63, 1041-1049.
15. Leung PS, Fung ML & Tam MS (2003). Renin-angiotensin system in the carotid body. Int J Biochem Cell Biol 35, 847-854.
16. Li YL, Ding Y, Agnew C & Schultz HD (2008). Exercise training improves peripheral chemoreflex function in heart failure rabbits. J Appl Physiol 105, 782-790.
17. Li YL, Gao L, Zucker IH & Schultz HD (2007). NADPH oxidase-derived superoxide anion mediates angiotensin II-enhanced carotid body chemoreceptor sensitivity in heart failure rabbits. Cardiovasc Res 75, 546-554.
18. Li YL, Li YF, Liu D, Cornish KG, Patel KP, Zucker IH, Channon KM & Schultz HD (2005). Gene transfer of neuronal nitric oxide synthase to carotid body reverses enhanced chemoreceptor function in heart failure rabbits. Circ Res 97, 260-267.
19. Li YL & Schultz HD (2006). Enhanced sensitivity of Kv channels to hypoxia in the rabbit carotid body in heart failure: role of angiotensin II. J Physiol 575, 215-227.
20. Li YL, Xia XH, Zheng H, Gao L, Li YF, Liu D, Patel KP, Wang W & Schultz HD (2006). Angiotensin II enhances carotid body chemoreflex control of sympathetic outflow in chronic heart failure rabbits. Cardiovasc Res 71, 129-138.
21. Marcus NJ, Del Rio R, Schultz EP, Xia XH & Schultz HD (2014). Carotid body denervation improves autonomic and cardiac function and attenuates disordered breathing in congestive heart failure. J Physiol 592, 391-408.
22. Miyakawa AA, de Lourdes Junqueira M & Krieger JE (2004). Identification of two novel shear stress responsive elements in rat angiotensin I converting enzyme promoter. Physiol Genomics 17, 107-113.
23. Niewiński P, Janczak D, Rucinski A, Jazwiec P, Sobotka PA, Engelman ZJ, Fudim M, Tubek S, Jankowska EA, Banasiak W, Hart EC, Paton JF & Ponikowski P (2013). Carotid body removal for treatment of chronic systolic heart failure. Int J Cardiol 168, 2506-2509.
24. Ponikowski P, Chua TP, Anker SD, Francis DP, Doehner W, Banasiak W, Poole-Wilson PA, Piepoli MF & Coats AJ (2001). Peripheral chemoreceptor hypersensitivity: an ominous sign in patients with chronic heart failure. Circulation 104, 544-549.
25. 2S) in hypoxic sensing by the carotid body. Respir Physiol Neurobiol 184, 165-169.
26. Schultz HD, Li YL & Ding Y (2007). Arterial chemoreceptors and sympathetic nerve activity: implications for hypertension and heart failure. Hypertension 50, 6-13.
27. Schultz HD & Marcus NJ (2012). Heart failure and carotid body chemoreception. Adv Exp Med Biol 758, 387-395.
28. Schultz HD, Marcus NJ & Del Rio R (2013). Role of the carotid body in the pathophysiology of heart failure. Curr Hypertens Rep 15, 356-362.
29. Sun SY, Wang W, Zucker IH & Schultz HD (1999). Enhanced activity of carotid body chemoreceptors in rabbits with heart failure: role of nitric oxide. J Appl Physiol 86, 1273-1282.
30. Wang T, Lang GD, Moreno-Vinasco L, Huang Y, Goonewardena SN, Peng YJ, Svensson EC, Natarajan V, Lang RM, Linares JD, Breysse PN, Geyh AS, Samet JM, Lussier YA, Dudley S, Prabhakar NR & Garcia JG (2012). Particulate matter induces cardiac arrhythmias via dysregulation of carotid body sensitivity and cardiac sodium channels. Am J Respir Cell Mol Biol 46, 524-531.
31. Xing DT, May CN, Booth LC & Ramchandra R (2014). Tonic arterial chemoreceptor activity contributes to cardiac sympathetic activation in mild ovine heart failure. Exp Physiol 99, 1031-1041.
32. Yang RF, Yin JX, Li YL, Zimmerman MC & Schultz HD (2011). Angiotensin-(1-7) increases neuronal potassium current via a nitric oxide-dependent mechanism. Am J Physiol Cell Physiol 300, C58-C64.
33. Zoccal DB & Machado BH (2011). Coupling between respiratory and sympathetic activities as a novel mechanism underpinning neurogenic hypertension. Curr Hypertens Rep 13, 229-236.